Weili Zhao

机构：Hebei Medical University, Tianjin University, Shanghai Jiao Tong University, Sichuan University, Ruijin Hospital, Second Hospital of Hebei Medical University, Tianjin Children's Hospital, Beijing Jingshida Electromechanical Equipment Research Institute, Institut Français de la Vigne et du Vin, Sinotech Genomics (China), Shanghai Institute of Hematology · ORCID：0000-0002-6834-1616

发表论文 218 篇 · 总被引 9206 次 · h-index 30

代表论文

• Ionizable Coenzyme‐Engineered Lipid/Fiber Microplexes Boost Ribosomal Translation to Improve mRNA Therapy for Degenerative Diseases (2025 · Advanced Materials · 被引 8)
• Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06) (2025 · Signal Transduction and Targeted Therapy · 被引 8)
• Mechano-crosstalk between living and artificial cells (2025 · Nature Communications · 被引 7)
• An mRNA microsphere vaccine inhibiting overactivation of DNA sensing mechanisms (2025 · 中国科学通报：英文版 · 被引 6)
• A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma (2025 · Blood · 被引 5)
• An LLM-enhanced knowledge service methodology for manufacturing process planning based on task- guided multi-layer knowledge graph (2026 · Journal of Manufacturing Systems · 被引 3)